drugset / Trial / NCT00759083
Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients
NaSingle-groupOpen-labelPrevention
Summary
To monitor the frequency of the development of thrombocytopenia in patients with Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome receiving bivalirudin during Percutaneous Coronary Intervention
Timeline
- Start
- 2008-09
- Primary completion
- 2009-09
- Completion
- 2010-05-10
Outcome
Outcome not reported
Stopped (Enrollment): “The study was discontinued early due to inadequate patient enrollment. No patients were enrolled.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bivalirudin | Peptide | 1.75 mg/kg | Intravenous |